What is the appropriate dose of Stemetil (prochlorperazine) for an adult patient with right eye ptosis and potential nausea or vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stemetil (Prochlorperazine) Dosing for Nausea and Vomiting

For nausea and vomiting in adults, the standard dose of Stemetil (prochlorperazine) is 5-10 mg orally 3-4 times daily, with a maximum of 40 mg per day. 1

Standard Adult Dosing

  • Begin with 5 mg or 10 mg orally 3-4 times daily for severe nausea and vomiting 1
  • Daily doses above 40 mg should only be used in resistant cases 1
  • Dosage should be adjusted based on individual response, starting with the lowest recommended dose 1

Context-Specific Recommendations

For Chemotherapy-Induced Nausea (Low Emetogenic Risk)

  • Prochlorperazine 10 mg orally every 6 hours as needed is recommended for low emetogenic chemotherapy agents 2
  • May be combined with dexamethasone 20 mg orally for enhanced effect 2
  • Can be used with or without lorazepam and with or without H2 blockers or proton pump inhibitors 2

For Opioid-Induced Nausea

  • Prochlorperazine 5-10 mg orally 3-4 times daily can be used as first-line prophylaxis when initiating opioid therapy 3
  • If nausea persists despite as-needed dosing, switch to scheduled around-the-clock administration for 1 week, then return to as-needed dosing 3

Special Population Considerations

Elderly Patients

  • Use lower doses within the recommended range as elderly patients are more susceptible to hypotension and neuromuscular reactions 1
  • Dosage should be increased more gradually and patients observed closely 1

Debilitated or Emaciated Patients

  • Dosage should be increased more gradually in these populations 1

Critical Safety Warnings

Extrapyramidal Symptoms Risk

  • Monitor closely for dystonic reactions and akathisia, which can occur within the first week of treatment 2, 4
  • The incidence of extrapyramidal symptoms with prochlorperazine is approximately 14% 4
  • Diphenhydramine can be used to treat dystonic reactions if they occur 2
  • Benztropine may be used in patients allergic to diphenhydramine 2

Tardive Dyskinesia Risk

  • Long-term use carries risk of tardive dyskinesia, a potentially irreversible movement disorder 5
  • Consider alternative antiemetics (ondansetron, granisetron) for prolonged treatment to avoid this risk 5

Regarding the Ptosis

The right eye ptosis mentioned in your clinical context is unrelated to prochlorperazine dosing for nausea. If the ptosis is related to myasthenia gravis, topical oxymetazoline hydrochloride 0.1% has shown efficacy in temporarily eliminating myasthenic ptosis for up to 7 hours 6. However, this is a separate therapeutic consideration from antiemetic management and should be addressed through appropriate neuromuscular or ophthalmologic consultation 2.

Common Pitfalls to Avoid

  • Do not use prochlorperazine in children under 20 pounds or under 2 years of age 1
  • Do not exceed 40 mg daily in routine cases without clear justification for resistant symptoms 1
  • Avoid prolonged use without reassessing the need, given tardive dyskinesia risk 5
  • When converting from liquid to crushed tablet formulations, doses may not be equivalent and require adjustment 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Nausea After Starting Gabapentin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline.

Optometry and vision science : official publication of the American Academy of Optometry, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.